RVMD Begins Phase 3 Trial
Revolution Medicines starts treating patients in a Phase 3 clinical trial evaluating Zoldonrasib for RAS G12D metastatic pancreatic cancer
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.